SCHEMBL5318834

SCHEMBL5318834

NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1

nearest known ligand 0.35

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 3/20 0.35
▸ STAT3 P40763 1/20 0.32
▸ PTPN1 P18031 4/20 0.30
▸ PTPN2 P17706 1/20 0.30
▸ PTPRA P18433 1/20 0.30
▸ PTPN6 P29350 1/20 0.30
▸ PTPN11 Q06124 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5318838 0.93 UTS2R (0.32) MME
SCHEMBL5318831 0.93 UTS2R (0.32) MME
SCHEMBL29851664 0.88 MME (0.38) MME
SCHEMBL30038078 0.87 MME (0.39) MME
SCHEMBL29461516 0.87 MME (0.44) MME
SCHEMBL29761682 0.86 MME (0.43) MME
SCHEMBL29598237 0.85 MME (0.40) MME
SCHEMBL24525829 0.85 ERAP2 (0.35) MME
SCHEMBL31229006 0.84 ACE (0.38) MME
SCHEMBL1371052 0.84 OPRD1 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007095583-A2 METHODS FOR TREATING CANCER AND SENSITIZING CANCER CELLS USING THE SERINE PROTEASE INHIBITOR, MASPIN CHILDREN'S MEMORIAL RESEARCH CENTER (US) 2007-08-23 — — WO disclosed
EP-1805219-A1 ANGIOPOIETIN-2 SPECIFIC BINDING AGENTS Amgen, Inc (US) 2007-07-11 — — EP disclosed
WO-2006045049-A1 ANGIOPOIETIN-2 SPECIFIC BINDING AGENTS AMGEN INC. (US) 2006-04-27 — — WO disclosed
Send feedback